CIDP
18 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Biorepository and Registry for Plasma Exchange Patients (NCT05004493) | Charles M Knudson | 2021-07-28 |
| Biomarkers in Polyradiculoneuropathies (NCT04249752) | University Hospital, Montpellier | 2020-01-01 |
| Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation (NCT03801135) | University Medical Centre Ljubljana | 2018-10-03 |
| Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT02629796) | Fondation Ophtalmologique Adolphe de Rothschild | 2014-04-16 |
| Change of Nerve Conduction Properties in IVIg Dependent Neuropathies (NCT01655394) | University of Cologne | 2012-10-01 |
| Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy (NCT00962429) | Oregon Health and Science University | 2009-02-01 |
| Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT04777734) | argenx |
Track CIDP automatically
Every clearance here is in the API, with alerts when new ones post.